The Bench to Bedside Initiative (BBI), Hacking Health NYC and our partner healthcare organizations bring you the “Commercializing Life Science – Business Matchmaking” event to gather a diverse group of people from academic research, technology, healthcare/medicine and the business communities to address innovation in healthcare.

What to Expect:

The purpose of the event is to form successful teams—comprised of specialists in business, legal, technology and medical research—who will work with patented life science technologies with BBI members.

Keynote Speaker: Piraye Beim, Founder and CEO, Celmatix Inc.